BRTXQ would only have to run to .01 or .015 to equal what OPT*I has done. Methinks the possible gains here are much much much more. People had completely given up on this ticker, seeing as the Desmaris offer was so low. Now that their drug (platform/treatment) candidates have struck gold and AUCTUS has jumped into the fray, it's a night and day difference, is it not?